• News
  • June 12, 2017
Demand to increase the list of National List of Essential Medicines (NLEM)

New Delhi : The list of Essential Medicines has been revised every two years after the concept of Essential Medicines introduced by WHO in 1977. The medicines those are required…

Shortage of drugs forecast for mid-June 2017

New Delhi : Monsoon season carries several seasonal diseases alongside and it increases the demand for the medicines to cure these diseases. There may be a shortage of the medicines…

Gelatin capsules may disappear soon in the India

New Delhi : The government received recommendations to use cellulose capsules, that are originated from plants are safe to use in comparison of gelatin capsules.  The Central Drugs Standard Control…

Strike against the intervention of government into medical field

New Delhi : A strike called by Indian Medical Association (IMA) on 6th June 2017 to demand a change in the government rules to free the medical professionals from the…

A demand of the law to ensures the quality of generic medicines and affordability to the users.

New Delhi : Indian Govt. should need to focus more on the assurance of the quality and affordability of the generic medicines with a law type RERA to regulate manufacturing…

Latest Indian Govt. decisions will change the face of the Pharma Sector

New Delhi : Here comes a time to see how Govt. decisions shape Indian Pharma industry. Indian Govt. implemented GST for Pharma manufacturers to control the prices of medicines and…

Important note for merchants

Baldev Malhotra : Tomorrow is the date of 01-06-2017 GST Migration and DSC uploading process for 15 days. So all dealers should use this opportunity. It has already been sent…

Bike rally held in Sangareddy Town Telangana against E-Portal

  Baldev Malhotra : The closure of Telangana was completely successful with the shutdown of the one-day nationwide call called on the call of AIOCD. In the protest against the…

Impacts of Trump’s policy and US Pharma market on the Sun Pharmaceutical companies.

New Delhi: Sun Pharmaceutical Managing Director, Dilip Shanghvi expressing concerns over the Trump administration that makes U.S. market conditions tough for Indian generic pharma manufacturers. He also added that the U.S.…

What leads Top 5 Pharma Companies to face Loss of 19,000 Crore in the Market Value?

New Delhi : After a report of weak set of profits from Taro pharmaceutical (US-based subsidiary of Sun Pharmaceutical) fresh selloff in the pharmaceutical shares has been triggered. Pharma traders…